-- Anticoagulants have been used for over 80 years to treat clotting disorders. It is used as a first line of defense for disorders such as deep vein thrombosis (DVT), pulmonary embolism, AF, and acute coronary syndrome. With the advent of time, traditional therapies are replaced by novel oral anticoagulants, which have better safety and efficacy profiles.
The 1990s saw rapid development in the field of direct thrombin inhibitors. Though these drugs, such as hirudin, have been in use from the early 19th century, they were accepted with the development of genetic engineering technology. The recombinant forms, such as desirudin, are also available in the market. During the same period, the focus shifted toward the development of factor Xa inhibitors, and by early 2000s, the first indirect factor Xa inhibitor, fondaparinux, was released into the market. These drugs were administered by parenteral route.
Publisher's analysts forecast the anti-coagulants market in the US to grow at a CAGR of 6.67% during the period 2016-2020.
Complete Report Available at: http://www.reportsweb.com/anticoagulants-market-in-the-us-2016-2020 .
Covered in this report
The report covers the present scenario and the growth prospects of the anti-coagulants market in the US for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded and generics drugs used to treat coagulation disorders. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market.
Publisher's report, Anti-Coagulants Market in the US 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
-Johnson & Johnson
-Bristol-Myers Squibb
-Boehringer Ingelheim
-Sanofi
-Daiichi Sankyo
Get Sample of the Report at: http://www.reportsweb.com/inquiry&RW0001242763/sample .
Other prominent vendors
-Armatheon Inc.
-Aspen
-AstraZeneca
-Bayer
-Cellceutix
-Cosmo Pharmaceuticals SA
-CSL Behring, Eisai, GSK
-Marathon Pharmaceuticals LLC
-Ockham Biotech
-Perosphere
-Portola Pharmaceuticals
-Sagent Pharmaceuticals Inc.
-The Medicines Company
-Urigen Pharmaceuticals Inc.
-Valeant Pharmaceuticals
Market driver
-Growing prevalence of coagulation disorders
-For a full, detailed list, view our report
Market challenge
-Side-effects associated with drugs
-For a full, detailed list, view our report
Market trend
-Expected exploitation of new therapeutic use
-For a full, detailed list, view our report
Inquire about Report at: http://www.reportsweb.com/inquiry&RW0001242763/buying .
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Anticoagulants: An overview
PART 06: Reimbursement scenario
PART 07: Anticoagulant reversal agents
PART 08: Approved anticoagulants in US
PART 09: Anticoagulants pipeline portfolio
PART 10: Market landscape
PART 11: Market segmentation by ROA
PART 12: Market segmentation by drug class
PART 13: Market segmentation by application
PART 14: Market drivers
PART 15: Impact of drivers
PART 16: Market challenges
PART 17: Impact of drivers and challenges
PART 18: Market trends
PART 19: Vendor landscape
PART 20: Appendix
Purchase this Report at: http://www.reportsweb.com/buy&RW0001242763/buy/2500 .
Contact Info:
Name: Sameer Joshi
Email: Send Email
Organization: ReportsWeb
Address: Pune, India.
Phone: +1-646-491-9876
Website: http://www.reportsweb.com/anticoagulants-market-in-the-us-2016-2020
Release ID: 171793
Google
RSS